Filing Flows

Filing Flows › Nephros (NEPH) › Q2 2025

Nephros (NEPH) Q2 2025 earnings results (second quarter 2025)

10-Q filed Aug 7, 2025

Nephros (NEPH) reported revenue of $4.4M for the second quarter 2025 (Q2 2025), +36% from a year earlier and -9% from the quarter before. Operating margin was 5.6%, net earnings $237K (5.4% of revenue).

Revenue$4.4M
Year over year+36%
Quarter over quarter-9%
Operating margin5.6%
Net earnings$237K

Nephros, Q2 2025: revenue $4.4M (+36% year over year), operating margin 5.6%, net earnings $237K, operating cash flow $994K. The chart follows the revenue to costs, profit and cash.

Q2 2025AmountQ/QY/Y
Revenue$4.4M-9%+36%
Gross profit$2.8M-11%+46%
Operating profit$248K-56%—
Net earnings$237K-58%—
Operating cash flow$994K+209%—

What changed

Revenue was $4.4M in Q2 2025, up 36% year over year and down 9% from the previous quarter. Product was the largest line at 98% of revenue. Product added $1.1M year over year (up 34%), 95% of the total change.

Gross margin was 63.2%, up 4.5 points from a year earlier. Operating profit was $248K, a 5.6% margin (up 15.4 points year over year). Operating expenses grew 14% against revenue growth of 36%. The fastest-growing cost line was Research & development (+22%). Net earnings were $237K. The effective tax rate was 3.7%.

Operating cash flow was $1.0M, 419% of net earnings. Non-cash charges added back $35K of depreciation and amortization and $71K of share-based compensation. Working capital and other items added $651K.

Questions

What was Nephros' revenue in the second quarter 2025?

Nephros (NEPH) reported revenue of $4.4M for the second quarter 2025 (Q2 2025), +36% from a year earlier and -9% from the quarter before.

Was Nephros profitable in the second quarter 2025?

Operating profit was $248K (5.6% of revenue) and net earnings $237K.

Open the interactive Sankey →

Source: Nephros 10-Q on SEC EDGAR.